Standardized uptake values are adequate measures of [18F]DCFPyL PSMA PET/CT uptake in patients with low prostate cancer disease burden

by Y.J.L. Bodar, B.P.F. Koene, B.H.E. Jansen, M.C.F. Cysouw, D. Meijer, N.H. Hendrikse, A.N. Vis, R. Boellaard, D.E. Oprea-Lager
Published 2020-11-01

Determining the diagnostic value of PSMA-PET/CT imaging in patients with persistent high prostate specific antigen levels and negative prostate biopsies. The SESAME-study

by Y.J.L. Bodar, B.P.F. Koene, D. Meijer, P.J. Van Leeuwen, J.A. Nieuwenhuijzen, R.J.A. Van Moorselaar, N.H. Hendrikse, D.E. Oprea-Lager, A.N. Vis
Published 2020-11-01

Biochemical persistence of prostate-specific antigen after robot-assisted laparoscopic radical prostatectomy: Tumor localizations using PSMA PET/CT imaging

by D. Meijer, M.L. Donswijk, Y.J.L. Bodar, P.J. Van Leeuwen, H.G. Van Der Poel, W.V. Vogel, J.A. Nieuwenhuijzen, N.H. Hendrikse, D.E. Oprea-Lager, A.N. Vis
Published 2020-11-01

Patients with biochemical recurrence after radical prostatectomy and local recurrence or negative PSMA PET/CT are excellent candidates for salvage radiotherapy to the prostatic fos...

by H.B. Luiting, D. Meijer, P.J. Van Leeuwen, S. Remmers, H.G. Van Der Poel, T. Witteveen, Y.J.L Bodar, D.E. Oprea-Lager, B.H.E. Jansen, M.J. Roobol, A.N. Vis
Published 2020-07-01

Determining the predictive value of a pre-operative negative PSMA PET/CT in candidates for radical prostatectomy and extended pelvic lymph node dissection

by D. Meijer, H. De Barros, Y.J.L. Bodar, P.J. Van Leeuwen, B.H.E. Jansen, T.M. Van Der Sluis, H.G. Van Der Poel, J.A. Nieuwenhuijzen, D.E. Oprea-Lager, A.N. Vis
Published 2020-11-01

Photophysical properties of polynuclear complexes containing phenylpyridine-iridium(III) units

by Mohd Ali, Noorshida
Published 2013